skip to the content
The Burden of RA Disease
- Rheumatoid arthritis (RA) is a chronic, destructive, inflammatory autoimmune disease.1
- The World Health Organization estimates that RA affects 23.7 million people worldwide,2 with a prevalence of 0.3–1.0% of the adult population.3
- Around twice as many women as men are affected.3
- As the disease progresses, patients with RA suffer significant disability and a marked reduction in their quality of life.1
- An estimated 40% of patients with RA will be unable to work within 5 years of diagnosis, and 50% within 10 years.4
- The burden of RA therefore includes:
- Direct effects on a patient’s ability to carry out normal daily tasks (view video)
- A significant impact on a patient’s quality of life
- Economic implications – for patients, their families and the healthcare system.
- Smolen JS & Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003; 2:473–488.
- World Health Organization. The global burden of disease: 2004 update. Geneva: WHO Press, 2008.
- Symmons D, et al. The global burden of rheumatoid arthritis in the year 2000. 2006.
- National Institute for Health and Clinical Excellence. RA in Adults: Final Scope. 2007.